Encapsulating biological active substances into erythrocytes |
| We claim: 1. A process for the encapsulation in human or animal erythrocytes of at least one ... |
|
Flow chamber and electro-manipulator incorporating same |
| Accordingly, an object of the present invention is to provide a flow chamber and an electro-... |
|
Probe for electrofusion, electroporation, or like procedure |
| The present invention provides a structure and method for treating samples in a well tray. Briefly, ... |
|
Device and method for the electrophoretic separation of macromolecules |
| The invention relates to an electrophoresis device and an electrophoresis method for the separation ... |
|
Superfusion apparatus |
| It is an object of the present invention to provide a superfusion apparatus for use in receptor ... |
|
Electroporation device |
| I claim: 1. An electroporation apparatus for electroporating living cells with molecules comprising:... |
|
Implantable electroporation method and apparatus for drug and gene delivery |
| Accordingly, it is the primary object of the present invention to provide an improved method of ... |
|
Flow electroporation chamber with electrodes having a crystalline metal nitride coating |
| The present invention provides improved electrodes for use in generating an electrical field in a ... |
|
|
ppRB.sup.110 -phosphoprotein the retinoblastoma susceptibility gene product
| Details |
Inventors: Lee, Wen-Hwa; Lee, Eva Y. - H. P.;
Assignee: The Regents of the University of California (Berkeley, CA)
Primary Examiner: Kepplinger; Esther M.
Assistant Examiner: Hoffer; Florina B.
Attorney, Agent or Firm: Kleinke; Bernard L., Waters; William Patrick, Potts; Jerry R.
This invention relates in general to a phosphoprotein product of the retinoblastoma susceptibility gene. In particular, this invention relates to a phosphoprotein ppRB.sup.110 primarily located in the cell nucleus which has a DNA binding activity. The invention also relates to the amino acid sequence of the phosphoprotein and to the specific purified anti-retinoblastoma phosphoprotein antibody. The invention further relates to a method of diagnosing retinoblastoma and other retinoblastoma gene involved cancers, treating such kind of cancers and regulating the oncogenicity of other genes. |
|
DETAILED DESCRIPTION OF FIGURES FIG. 1 is the chromatogram illustrating the identification of RB proteins by immunoprecipitation with rabbit anti-RB IgG in various cell lines. Human cells such as neuroblastoma LAN-1 (Lanes 1 and 2), Alexander hepatoma (Lane 3), osteosarcoma U20S (Lane 4), normal fibroblasts (Lane 5), and five retinoblastomas (Lanes 6 to 10) were labeled with . sup. 35 S-methionine and immunoprecipitated with preimmune rabbit IgG (Lane 1) or rabbit anti-RB IgG (Lanes 2-10). The immunoprecipitates were analyzed by 7. 5% SDS-polyacrylamide gel electrophoresis and autoradiographed. FIG. 2 is the complete RB cDNA nucleotide sequences and predicted amino acid sequences of the RB protein. The most 5' . about. 240 nucleotides were obtained from a cDNA clone from retinoblastoma cell line Y79. Nucleotide sequences from this clone and the original normal RB clones were aligned by sequence overlap. The first and second initiation sites are boxed, and alanine and proline clusters underlined. FIG. 3 is the chromatogram illustrating the modifications of the RB protein. LAN-1 cells were labeled with . sup. 35 S-methionine (lanes 1-3) or . sup. 32 P-phosphoric acid (0. 5 mci/ml) (lanes 4 and 5) for three hours. Cellular lysates were immunoprecipitated with preimmune rabbit IgG (lane 1 and 4) or anti-RB IgG (lanes 2, 3 and 5). Aliquots of . sup. 35 S-methionine-labeled RB proteins were digested with Endoglycosidase H (ICN ImmunoBiologicals) overnight (lane 3). These immunoprecipitates were then analyzed by 7. 5% SDS-polyacrylamide gel as described in FIG. 1. The RB gene product was found to be phosphorylated but not glycosylated. FIG. 4 is the chromatogram illustrating a conservation of the RB gene product in different vertebrate species. Cell lines of human neuroblastoma, LAN-5, (Lanes 1 and 2), monkey, cos, (lanes 3 and 4), quail fibroblast, QT6, (Lanes 5 and 6), mouse fibroblast, NIH/3T3, (Lanes 7 and 8), and rat fibroblast, rat-2, (Lanes 9 and 10) were labeled with . sup. 32 P-phosphoric acid and immunoprecipitated with preimmune IgG (odd numbered lanes) or anti-RB IgG (even numbered lanes) and analyzed as described in FIG
|
|